Bernadette Connaughton

Insider profile

Currently holds a position at Syneos Health Inc

Bernadette Connaughton's trades of Halozyme Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-02 2026-07-01 PlS Planned sale
15,403 -25.2%
428.65
US$4,686,351
15,403 -25.2% 428.65 US$4,686,351
2026-07-02 2026-07-01 PlS Planned sale
86,497 -43.3%
164.63
US$4,491,491
86,497 -43.3% 164.63 US$4,491,491
2026-06-02 2026-06-01 PlS Planned sale
6,276 +36.9%
228.23
US$124,184
6,276 +36.9% 228.23 US$124,184
2026-05-05 2026-05-01 PlS Planned sale
1,625 -4.1%
63.48
US$103,155
1,625 -4.1% 63.48 US$103,155
2026-05-01 2026-05-01 PrS Proposed sale
4,875
63.66
US$310,342
4,875 63.66 US$310,342
2026-01-06 2026-01-05 PlS Planned sale
2,000 -4.7%
70.25
US$140,500
2,000 -4.7% 70.25 US$140,500
2026-01-05 2026-01-05 PrS Proposed sale
2,000
70.31
US$140,620
2,000 70.31 US$140,620
2025-12-01 2025-12-01 PlS Planned sale
829 -1.9%
71.60
US$59,356
829 -1.9% 71.60 US$59,356
2025-11-12 2025-11-10 PlS Planned sale
2,000 -4.4%
68.48
US$136,960
2,000 -4.4% 68.48 US$136,960
2025-10-01 2025-10-01 PlS Planned sale
500 -1.1%
75.70
US$37,852
500 -1.1% 75.70 US$37,852
2025-10-01 2025-10-01 PlS Planned sale
1,500 -3.2%
75.09
US$112,629
1,500 -3.2% 75.09 US$112,629
2025-09-02 2025-09-02 PrS Proposed sale
8,829
73.15
US$645,841
8,829 73.15 US$645,841
2025-09-02 2025-09-02 PlS Planned sale
923 -1.9%
74.11
US$68,404
923 -1.9% 74.11 US$68,404
2025-09-02 2025-09-02 PlS Planned sale
2,977 -5.9%
73.62
US$219,161
2,977 -5.9% 73.62 US$219,161
2025-09-02 2025-09-02 PlS Planned sale
100 -0.2%
71.71
US$7,171
100 -0.2% 71.71 US$7,171